Mar 3, 2026 | Homepage News, News, Uncategorized
PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2 – PRF’s investigational gene-editing therapy designed to correct the gene mutation that causes Progeria. This is a defining step toward Progeria gene therapy clinical trials....
Nov 1, 2025 | Events, Homepage News, Uncategorized
General Information Registration Workshop Sponsors Agenda Speakers Poster Abstract Submission Location and Travel PRF’s 12th International Scientific Workshop: Breakthroughs, Community & Hope In October 2025, 118 physicians, scientists, and advocates from 12...
Sep 25, 2025 | Homepage News, News, Uncategorized
Collaboration = Progress The Progerinin trial is a partnership between PRF, trial sponsor PRG Science & Technology (a Korean- based biotech company), Boston Children’s Hospital (the trial site), Brigham and Women’s Hospital (site for some trial tests), and of...
Aug 8, 2025 | Homepage News, News, Uncategorized
As described in the August 11, 2025, front-page New Yorker article**, entitled How an Ultra-Rare Disease Accelerates Aging, The Progeria Research Foundation is thrilled to announce the pioneering Progeria Gene Editing Program. **Click here to read the full article....
Jun 29, 2025 | News, Uncategorized
PRF is thrilled to announce that the first Progerinin clinical trial patient visits are complete! Earlier this month, we welcomed US-residents Merlin (23) and Kaylee (21) to their week-long trial visits at Boston Children’s Hospital. This groundbreaking trial...
May 29, 2025 | Events, Uncategorized
Give Join the Circle of Hope Become a Monthly Donor Matching Gifts Make a Planned Gift Donate Now More Ways to Give PARALLEL JOURNEYS Thanks to the FDA-approved treatment lonafarnib, those with Progeria are living longer and healthier lives, while PRF explores other...